Summary

Global Influenza Diagnostics Market 2023-2027
The influenza diagnostics market is forecasted to grow by USD 466.18 mn during 2022-2027, accelerating at a CAGR of 6.95% during the forecast period. The report on the influenza diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising incidence of influenza, growing demand for molecular diagnostics, and supportive government initiatives and funding.
Technavio's influenza diagnostics market is segmented as below:
By End-user
• Hospitals and diagnostic laboratories
• Academic and research centers
• Homecare
By Type
• Point-of-care testing
• Immunodiagnostics
• Molecular diagnostics
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the rising approvals for influenza diagnostic products as one of the prime reasons driving the influenza diagnostics market growth during the next few years. Also, the surge in a number of genetic characterization studies on the influenza virus and the rising adoption of rapid diagnostic products in physician office laboratories will lead to sizable demand in the market.
The report on the influenza diagnostics market covers the following areas:
• Influenza diagnostics market sizing
• Influenza diagnostics market forecast
• Influenza diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading influenza diagnostics market vendors that include Abbott Laboratories, Becton Dickinson and Co., BICO Group AB, Bio Rad Laboratories Inc., Biocartis Group NV, bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Hologic Inc., Princeton BioMeditech Corp., QIAGEN NV, Response Biomedical Corp., SA Scientific Ltd., Sd Biosensor Inc., Sekisui Chemical Co. Ltd., Siemens Healthineers AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Quidelortho Corp.. Also, the influenza diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/influenza-diagnostics-market-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global Influenza Diagnostics Market 2023-2027 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global influenza diagnostics market 2023-2027 2017 - 2021 ($ million)
o 4.2 End-user Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.3 Type Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by End-user
o 6.1 Market segments
o Exhibit 30: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 31: Data Table on End-user - Market share 2022-2027 (%)
o 6.2 Comparison by End-user
o Exhibit 32: Chart on Comparison by End-user
o Exhibit 33: Data Table on Comparison by End-user
o 6.3 Hospitals and diagnostic laboratories - Market size and forecast 2022-2027
o Exhibit 34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
o 6.4 Academic and research centers - Market size and forecast 2022-2027
o Exhibit 38: Chart on Academic and research centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Academic and research centers - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Academic and research centers - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Academic and research centers - Year-over-year growth 2022-2027 (%)
o 6.5 Homecare - Market size and forecast 2022-2027
o Exhibit 42: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Homecare - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Homecare - Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by End-user
o Exhibit 46: Market opportunity by End-user ($ million)
o Exhibit 47: Data Table on Market opportunity by End-user ($ million)
• 7 Market Segmentation by Type
o 7.1 Market segments
o Exhibit 48: Chart on Type - Market share 2022-2027 (%)
o Exhibit 49: Data Table on Type - Market share 2022-2027 (%)
o 7.2 Comparison by Type
o Exhibit 50: Chart on Comparison by Type
o Exhibit 51: Data Table on Comparison by Type
o 7.3 Point-of-care testing - Market size and forecast 2022-2027
o Exhibit 52: Chart on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Point-of-care testing - Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Point-of-care testing - Year-over-year growth 2022-2027 (%)
o 7.4 Immunodiagnostics - Market size and forecast 2022-2027
o Exhibit 56: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
o 7.5 Molecular diagnostics - Market size and forecast 2022-2027
o Exhibit 60: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Type
o Exhibit 64: Market opportunity by Type ($ million)
o Exhibit 65: Data Table on Market opportunity by Type ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 China - Market size and forecast 2022-2027
o Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.9 Germany - Market size and forecast 2022-2027
o Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.10 France - Market size and forecast 2022-2027
o Exhibit 99: Chart on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on France - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on France - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on France - Year-over-year growth 2022-2027 (%)
o 9.11 Canada - Market size and forecast 2022-2027
o Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 115: Abbott Laboratories - Overview
o Exhibit 116: Abbott Laboratories - Business segments
o Exhibit 117: Abbott Laboratories - Key news
o Exhibit 118: Abbott Laboratories - Key offerings
o Exhibit 119: Abbott Laboratories - Segment focus
o 12.4 Becton Dickinson and Co.
o Exhibit 120: Becton Dickinson and Co. - Overview
o Exhibit 121: Becton Dickinson and Co. - Business segments
o Exhibit 122: Becton Dickinson and Co. - Key news
o Exhibit 123: Becton Dickinson and Co. - Key offerings
o Exhibit 124: Becton Dickinson and Co. - Segment focus
o 12.5 BICO Group AB
o Exhibit 125: BICO Group AB - Overview
o Exhibit 126: BICO Group AB - Business segments
o Exhibit 127: BICO Group AB - Key offerings
o Exhibit 128: BICO Group AB - Segment focus
o 12.6 Bio Rad Laboratories Inc.
o Exhibit 129: Bio Rad Laboratories Inc. - Overview
o Exhibit 130: Bio Rad Laboratories Inc. - Business segments
o Exhibit 131: Bio Rad Laboratories Inc. - Key news
o Exhibit 132: Bio Rad Laboratories Inc. - Key offerings
o Exhibit 133: Bio Rad Laboratories Inc. - Segment focus
o 12.7 Biocartis Group NV
o Exhibit 134: Biocartis Group NV - Overview
o Exhibit 135: Biocartis Group NV - Product / Service
o Exhibit 136: Biocartis Group NV - Key offerings
o 12.8 bioMerieux SA
o Exhibit 137: bioMerieux SA - Overview
o Exhibit 138: bioMerieux SA - Product / Service
o Exhibit 139: bioMerieux SA - Key offerings
o 12.9 Danaher Corp.
o Exhibit 140: Danaher Corp. - Overview
o Exhibit 141: Danaher Corp. - Business segments
o Exhibit 142: Danaher Corp. - Key news
o Exhibit 143: Danaher Corp. - Key offerings
o Exhibit 144: Danaher Corp. - Segment focus
o 12.10 DiaSorin SpA
o Exhibit 145: DiaSorin SpA - Overview
o Exhibit 146: DiaSorin SpA - Business segments
o Exhibit 147: DiaSorin SpA - Key news
o Exhibit 148: DiaSorin SpA - Key offerings
o Exhibit 149: DiaSorin SpA - Segment focus
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
o 12.12 Hologic Inc.
o Exhibit 155: Hologic Inc. - Overview
o Exhibit 156: Hologic Inc. - Business segments
o Exhibit 157: Hologic Inc. - Key news
o Exhibit 158: Hologic Inc. - Key offerings
o Exhibit 159: Hologic Inc. - Segment focus
o 12.13 Princeton BioMeditech Corp.
o Exhibit 160: Princeton BioMeditech Corp. - Overview
o Exhibit 161: Princeton BioMeditech Corp. - Product / Service
o Exhibit 162: Princeton BioMeditech Corp. - Key offerings
o 12.14 Quidelortho Corp.
o Exhibit 163: Quidelortho Corp. - Overview
o Exhibit 164: Quidelortho Corp. - Product / Service
o Exhibit 165: Quidelortho Corp. - Key offerings
o 12.15 Sd Biosensor Inc.
o Exhibit 166: Sd Biosensor Inc. - Overview
o Exhibit 167: Sd Biosensor Inc. - Product / Service
o Exhibit 168: Sd Biosensor Inc. - Key offerings
o 12.16 Siemens Healthineers AG
o Exhibit 169: Siemens Healthineers AG - Overview
o Exhibit 170: Siemens Healthineers AG - Business segments
o Exhibit 171: Siemens Healthineers AG - Key news
o Exhibit 172: Siemens Healthineers AG - Key offerings
o Exhibit 173: Siemens Healthineers AG - Segment focus
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 174: Thermo Fisher Scientific Inc. - Overview
o Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 176: Thermo Fisher Scientific Inc. - Key news
o Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 179: Inclusions checklist
o Exhibit 180: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 181: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 182: Research methodology
o Exhibit 183: Validation techniques employed for market sizing
o Exhibit 184: Information sources
o 13.5 List of abbreviations
o Exhibit 185: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global influenza diagnostics market 2023-2027 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on End-user - Market share 2022-2027 (%)
Exhibits31: Data Table on End-user - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Hospitals and diagnostic laboratories - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Hospitals and diagnostic laboratories - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Academic and research centers - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Academic and research centers - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Academic and research centers - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Academic and research centers - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Homecare - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Homecare - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Homecare - Year-over-year growth 2022-2027 (%)
Exhibits46: Market opportunity by End-user ($ million)
Exhibits47: Data Table on Market opportunity by End-user ($ million)
Exhibits48: Chart on Type - Market share 2022-2027 (%)
Exhibits49: Data Table on Type - Market share 2022-2027 (%)
Exhibits50: Chart on Comparison by Type
Exhibits51: Data Table on Comparison by Type
Exhibits52: Chart on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Point-of-care testing - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Point-of-care testing - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Point-of-care testing - Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Molecular diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Molecular diagnostics - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Type ($ million)
Exhibits65: Data Table on Market opportunity by Type ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: Becton Dickinson and Co. - Overview
Exhibits121: Becton Dickinson and Co. - Business segments
Exhibits122: Becton Dickinson and Co. - Key news
Exhibits123: Becton Dickinson and Co. - Key offerings
Exhibits124: Becton Dickinson and Co. - Segment focus
Exhibits125: BICO Group AB - Overview
Exhibits126: BICO Group AB - Business segments
Exhibits127: BICO Group AB - Key offerings
Exhibits128: BICO Group AB - Segment focus
Exhibits129: Bio Rad Laboratories Inc. - Overview
Exhibits130: Bio Rad Laboratories Inc. - Business segments
Exhibits131: Bio Rad Laboratories Inc. - Key news
Exhibits132: Bio Rad Laboratories Inc. - Key offerings
Exhibits133: Bio Rad Laboratories Inc. - Segment focus
Exhibits134: Biocartis Group NV - Overview
Exhibits135: Biocartis Group NV - Product / Service
Exhibits136: Biocartis Group NV - Key offerings
Exhibits137: bioMerieux SA - Overview
Exhibits138: bioMerieux SA - Product / Service
Exhibits139: bioMerieux SA - Key offerings
Exhibits140: Danaher Corp. - Overview
Exhibits141: Danaher Corp. - Business segments
Exhibits142: Danaher Corp. - Key news
Exhibits143: Danaher Corp. - Key offerings
Exhibits144: Danaher Corp. - Segment focus
Exhibits145: DiaSorin SpA - Overview
Exhibits146: DiaSorin SpA - Business segments
Exhibits147: DiaSorin SpA - Key news
Exhibits148: DiaSorin SpA - Key offerings
Exhibits149: DiaSorin SpA - Segment focus
Exhibits150: F. Hoffmann La Roche Ltd. - Overview
Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
Exhibits152: F. Hoffmann La Roche Ltd. - Key news
Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits155: Hologic Inc. - Overview
Exhibits156: Hologic Inc. - Business segments
Exhibits157: Hologic Inc. - Key news
Exhibits158: Hologic Inc. - Key offerings
Exhibits159: Hologic Inc. - Segment focus
Exhibits160: Princeton BioMeditech Corp. - Overview
Exhibits161: Princeton BioMeditech Corp. - Product / Service
Exhibits162: Princeton BioMeditech Corp. - Key offerings
Exhibits163: Quidelortho Corp. - Overview
Exhibits164: Quidelortho Corp. - Product / Service
Exhibits165: Quidelortho Corp. - Key offerings
Exhibits166: Sd Biosensor Inc. - Overview
Exhibits167: Sd Biosensor Inc. - Product / Service
Exhibits168: Sd Biosensor Inc. - Key offerings
Exhibits169: Siemens Healthineers AG - Overview
Exhibits170: Siemens Healthineers AG - Business segments
Exhibits171: Siemens Healthineers AG - Key news
Exhibits172: Siemens Healthineers AG - Key offerings
Exhibits173: Siemens Healthineers AG - Segment focus
Exhibits174: Thermo Fisher Scientific Inc. - Overview
Exhibits175: Thermo Fisher Scientific Inc. - Business segments
Exhibits176: Thermo Fisher Scientific Inc. - Key news
Exhibits177: Thermo Fisher Scientific Inc. - Key offerings
Exhibits178: Thermo Fisher Scientific Inc. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Validation techniques employed for market sizing
Exhibits184: Information sources
Exhibits185: List of abbreviations